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Abstract
A retrospective nationwide survey on the occurrence of Capnocytophaga canimorsus and Capnocytopaga cynodegmi infections in The
Netherlands over 3 years showed 32 cases, of which 31 were caused by C. canimorsus and one by an unspeciﬁed oxidase-positive Capno-
cytophaga strain. Twenty-eight patients had been diagnosed by blood culture, one by culture from both blood and cerebrospinal ﬂuid
(CSF), one by culture from a conjunctival swab, and two patients by 16S rRNA gene ampliﬁcation by PCR directly from a blood or CSF
specimen. The incidence rate was 0.67 infections per million population. Bacteraemia was found in 94% of the cases. The age range of
patients was 38–80 years; 72% of them were male. Among 26 patients from whom clinical data were available, splenectomy was not
reported, but alcoholism was reported in ﬁve. Nine patients (35%) had been admitted to the intensive-care unit, and three patients
(13%) died. The mortality rate was much lower than observed in previous studies.
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Introduction
Capnocytophaga canimorsus occurs as a commensal in dogs’
mouths, but can give rise to a life-threatening infection in
humans. Sepsis has been reported as the most common
manifestation of infection with C. canimorsus [1], but other
infections, such as meningitis [2,3], endocarditis [4], mycotic
aneurysm [5], brain abscess [6] and endophthalmitis [7], have
also been reported. The incidence of C. canimorsus sepsis
was estimated to be 0.5 per million population in Denmark
during the period 1982–1995, with a case-fatality rate of 31%
[1]. A recently published study from California suggested an
increase in the frequency of the disease during recent years
[8]. Splenectomy and alcoholism have been reported as
important underlying conditions in C. canimorsus sepsis [9].
Most cases have been related to contact with dogs, but
infection after cat bites has also been described [10]. A
related species, Capnocytophaga cynodegmi, seems to be much
less virulent. Only ﬁve C. cynodegmi infections in humans have
been published, including one patient with a wound infection
[11], one with continuous ambulant peritoneal dialysis peri-
tonitis [12], two with cellulitis [13,14], one of whom had also
bacteraemia, and only one patient with severe sepsis [15].
Positive oxidase, katalase and arginine dihydrolase tests dis-
tinguish the two species from other Capnocytophaga species,
which occur as commensals in the human mouth and only
cause sepsis in highly immunocompromised patients [11].
As the few studies on the epidemiology of the disease were
published in the last decade of the last century, a nationwide
study to investigate the number of C. canimorsus and C. cyno-
degmi infections in The Netherlands was performed.
Materials and Methods
A questionnaire was sent to all 54 laboratories for clinical
microbiology in The Netherlands. In the questionnaire, the
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number of cases diagnosed in each laboratory in the period
2003–2005 was asked for. If cases had been diagnosed, data
on sex and age of the patient, origin of the strain, possible
risk factors, underlying diseases and outcome of the patient
were requested. In addition, the National Reference Labora-
tory of Bacteriology was contacted to look for strains that
had been submitted for identiﬁcation by clinical laboratories
from The Netherlands and that had been identiﬁed as C. ca-
nimorsus or C. cynodegmi. Laboratories that had sent the
strain to the National Reference Laboratory were contacted
for additional clinical information.
Results and Discussion
Fifty-three of 54 laboratories returned the questionnaire. Of
these laboratories, 19 had diagnosed at least one case of
C. canimorsus infection during the 3-year study period. All
together, 32 cases had been diagnosed (Table 1). Thirty-one
strains had been cultured from 30 patients. In two additional
patients, the diagnosis was established by direct sequencing
of PCR-ampliﬁed 16S rDNA from a blood sample and a
cerebrospinal ﬂuid (CSF) sample, respectively, a method pre-
viously described [16,17]. Thirty of the isolates had been
identiﬁed as C. canimorsus, 27 of them by 16S rRNA gene
sequencing. C. cynodegmi had never been identiﬁed during
these 3 years. One strain had only been identiﬁed as an oxi-
dase-positive Capnocytophaga strain, and will be regarded as
C. canimorsus in the clinical analysis. Of the strains, 29 had
been cultured from blood, one from CSF, and one from a
conjunctival swab. From one patient, a strain had been cul-
tured from both blood and CSF.
The number of C. canimorsus infections in The Nether-
lands was calculated as 32 cases among a population of 16
million in 3 years. The yearly incidence was therefore 0.67
per million, and the incidence of sepsis was 0.63 per million.
This is not signiﬁcantly different from the reported incidence
in Denmark (0.5 per million population). In the region com-
prising the north and east of The Netherlands, which are less
populated, the incidence was signiﬁcantly higher than
expected, whereas in the more populated region comprising
the west and centre, the incidence was lower (v2 = 15.9,
p 0.0004) (Fig. 1). Possible explanations could be a higher
incidence of dog bites or a greater delay in patients seeing
doctors in more rural areas.
The mean age of the patients was 60 years (range, 38–
80 years). Nine patients were female, and 23 were male. A
male predominance of this infection has been shown earlier
[9], but in this study, the number of female patients was not
signiﬁcantly below 50%. However, because of the small num-
ber of cases, this frequency may be misleading.
Data on risk factors and clinical outcome were reported
for 26 patients. Underlying diseases were reported in nine
patients. None of the patients was known to have had a pre-
vious splenectomy. Five patients had alcoholism, and in three
patients other underlying conditions were mentioned: one
had chronic obstructive pulmonary disease and low-dose
prednisone, and two had diabetes mellitus, one of whom had
TABLE 1. Characteristics of patients with Capnocytophaga
canimorsus infection
Total number of cases 32
Age (years), mean (range) 60 (38–81)
Sex (male/female) 23/9 (v2 = 3.21, NS)
Bacteriology
Positive culture 31a
Blood 29
CSF 1a
Eye swab 1
Positive PCR (blood) 1b
Positive PCR (CSF) 1b
With clinical data 26
Died 3 (12%)
ICU admission 9 (35%)c
Animal contact
Reported dog bite 13 (50%)
Wound licked by dog 3 (12%)
Reported cat bite 0
Reported spider bite 1 (4%)
Risk factors
Splenectomy 0
Alcoholism 5 (19%)
Other risk factors (see text) 3 (12%)
CSF, cerebrospinal ﬂuid; ICU, intensive-care unit; NS, not signiﬁcant.
aFrom one patient, a positive culture was obtained from both CSF and blood.
b16S rRNA gene ampliﬁcation.
cIncluding two of the patients who subsequently died.
Northern and eastern region
Observed cases: 19
Expected cases: 10
Population density: 288/km2
Western and central region 
Observed cases: 8       
Expected cases: 15 
Population density: 904/km2
Southern region           
Observed cases: 8
Expected cases: 6
Population density: 441/km2
Total number of cases = 35 
FIG. 1.Observed and expected number of Capnocytophaga canimor-
sus infections in different regions of The Netherlands.
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had a previous cerebrovascular accident and the other of
whom had hypertension.
A dog bite had been reported in 13 patients (50%). Three
additional patients had been licked on a wound by a dog, and
one patient had been scratched on the thorax by a dog. A
cat bite was not reported in any of the patients. Interestingly,
one patient reported a spider bite. This patient, a previously
healthy 50-year old male, was admitted because of confusion
and suspicion of bacterial meningitis. His C-reactive protein
on admission was 345 mg/L.
A lumbar puncture revealed numerous leukocytes in after
Gram staining, but no bacteria. The patient was treated with
penicillin G (3 million units, 6 times daily), and improved over
the next few days. Gram-negative rods grew from the anaero-
bic blood culture after 2 days and from the aerobic blood
culture bottle after 4 days. The patient improved gradually on
continued penicillin G treatment, which was stopped after
7 days. At that moment, the patient could be discharged from
the hospital in good condition; C-reactive protein was 8 mg/L.
The isolate from blood was subsequently characterized as
C. canimorsus by molecular methods. The only risk factor
that could be identiﬁed was that the patient had been bitten
by a spider while on holiday in Spain a month before; other-
wise, the course of his disease was not remarkably different
from that of the other patients in the study.
An additional patient, who was not included in the study,
because he developed the disease before the study period,
reported a bat bite. It is known that C. canimorsus also
occurs in other animals, such as cattle and sheep [18]. Fur-
ther studies should elucidate whether bats and even insects,
like spiders, are carriers of this bacterium.
The mortality rate among the patients was 3/26 (13%),
which is lower than reported in previous studies. A review
of all 103 published cases up to 1996 showed a mortality rate
of 30% [9]. In Denmark, the mortality rate in a nationwide
study performed between 1982 and 1995 was 12/39 (31%)
[1], and in California, a mortality rate of 30% (n = 30) was
reported between 1972 and 2004 [8]. The three patients
who died were 40, 45 and 69 years old, and were not among
the oldest patients. Moreover, the oldest patient of the
study, an 80-year-old man (patient 21), visited the outpatient
department for chills and fever, was orally treated with
amoxycillin–clavulanic acid, and had already recovered when
the culture results became known. In our study, intensive-
care unit admission was reported in nine patients (36%),
including two of the three patients who subsequently died.
Serious sequelae developed in two patients; in one of them,
both legs had to be amputated because of disseminated intra-
vascular coagulation. The low mortality rate in the present
study may also be the result of the low number of underlying
diseases among the patients; especially after splenectomy, a
severe course of the infection has been described [9].
One patient had a severe eye infection with C. canimorsus,
possibly a superinfection after herpes keratitis. In January
2005, this patient had already been treated for presumed
herpes keratitis with valacyclovir and local therapy with poly-
spectran and corticosteroids. In April 2005, the patient still
had blurred vision, and C. canimorsus was cultured from a
corneal swab of the affected eye. Prolonged therapy with
chloramphenicol and ciproﬂoxacin locally and clindamycin
orally was not successful. After several months, the affected
eye was enucleated because of prolonged inﬂammation and
blurred vision. The patient had two cats and no dogs; how-
ever, no direct contact between the cats and the patient’s
eye had been reported. A similar case has recently been
described in The Netherlands [7].
It should be acknowledged that a retrospective survey has
a number of potential pitfalls. Under-reporting by laborato-
ries may have occurred. The laboratories that responded
provide hospital care for approximately 98% of The Nether-
lands. Of course, cases may have been missed because of
inadequate sampling of materials, incorrect determination of
cultured strains, and inadequate reports by regional laborato-
ries. To include all cases, the National Reference Laboratory,
to which strains with identiﬁcation problems can be sent,
had also been contacted. This laboratory reported ten cases,
of which seven had also been reported by the regional labo-
ratories. Two laboratories had not yet responded, and
reported these cases afterwards. Only one strain had not
been found in the database of the laboratory where it was
originally cultured. Therefore, under-reporting by regional
laboratories does not seem to be a major problem. Almost
all strains had been characterized by 16S rRNA gene
sequencing, which might have some inadequacies in discrimi-
nating between C. canimorsus and C. cynodegmi [19], but is
nonetheless one of the best available methods.
Twenty-eight of 32 patients were diagnosed outside the
hospitals where the study was performed; therefore, no
direct access to patient charts was possible, and data on risk
factors, underlying diseases and outcome had to be based on
data obtained by the survey. In our questionnaire, we asked
explicitly about splenectomy and alcoholism, conditions that
have previously been described as associated with an
increased risk for C. canimorsus septicaemia. For about half of
the 17 patients in whom no underlying diseases were
reported, it was explicitly stated in the questionnaires that
the patient had no splenectomy or alcoholism. However,
regarding the other patients, clinical microbiologists usually
contact clinicians about these uncommon pathogens, and
would probably have noted important risk factors such as
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those mentioned above. Unfortunately, we did not ask for
data on antibiotic usage, on the initial diagnosis of the patient,
and on when the correct diagnosis had been made. These fac-
tors might all have inﬂuenced the outcome of the disease.
It is interesting that the number of patients with clearly
identiﬁable underlying diseases was low. The sex and age dis-
tribution of the infected patients corresponded to those in
earlier reports. Whereas a male predominance among the
patients could be related to an increased risk for dog bites
in men, the exclusive occurrence of the disease in middle-
aged and elderly persons points at waning immunity as a risk
factor for the disease. Possible virulence factors for the spe-
cies have recently been described, such as resistance to com-
plement and polymorphonuclear leukocytes [20], and
blocking of release of nitric oxide by lipopolysaccharide-acti-
vated macrophages [21], an ability not shared by most strains
isolated from dogs [22]. The low mortality rate in the pres-
ent study could well be a consequence of improvements in
hospital and ICU facilities. Further and more extensive stud-
ies should conﬁrm these hypotheses, and might clarify more
immune mechanisms behind this rare, but often serious,
infectious disease.
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